BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11770862)

  • 1. C-reactive protein and its role in the pathogenesis of myocardial infarction.
    Pepys MB; Hirschfield GM
    Ital Heart J; 2001 Nov; 2(11):804-6. PubMed ID: 11770862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application.
    Blake GJ; Ridker PM
    Ital Heart J; 2001 Nov; 2(11):796-800. PubMed ID: 11770860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events.
    Futterman LG; Lemberg L
    Am J Crit Care; 2002 Sep; 11(5):482-6. PubMed ID: 12233975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to use the C-reactive protein in cardiac disease?
    Ursella S; Mazzone M; Portale G; Testa A; Pignataro G; Covino M; Fenici P; Gasbarrini GB; Gentiloni Silveri N
    Minerva Cardioangiol; 2005 Feb; 53(1):59-68. PubMed ID: 15788980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherosclerosis and inflammation: the role of C-reactive protein].
    Ablij HC; Meinders AE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):15-20. PubMed ID: 12564292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and atherosclerosis: quo vadis?
    Koenig W; Torzewski J
    Ital Heart J; 2001 Nov; 2(11):801-3. PubMed ID: 11770861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH; Newby LK
    Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and atherothrombosis.
    Pepys MB; Hirschfield GM
    Ital Heart J; 2001 Mar; 2(3):196-9. PubMed ID: 11305531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [C-reactive protein in cardiovascular risk evaluation].
    Fabijanić D; Banić M; Kardum D
    Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein (CRP) in the cardiovascular system.
    Kanda T
    Rinsho Byori; 2001 Apr; 49(4):395-401. PubMed ID: 11391955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction.
    Goswami B; Rajappa M; Mallika V; Shukla DK; Kumar S
    Clin Chim Acta; 2009 Oct; 408(1-2):14-8. PubMed ID: 19576194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen.
    Wilson AM; Ryan MC; Boyle AJ
    Int J Cardiol; 2006 Jan; 106(3):291-7. PubMed ID: 16337036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-reactive protein in coronary plaques -- prevalence with acute coronary syndrome].
    Andrié R; Maylahn M; Braun P; Lüderitz B; Bauriedel G
    Z Kardiol; 2002 Nov; 91(11):913-20. PubMed ID: 12442194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
    J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein. Should it be considered a coronary risk factor?
    Aronow WS
    Geriatrics; 2003 May; 58(5):19-22, 25. PubMed ID: 12756677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.